RSS
Aquila BioMedical
Aquila BioMedical and Macrophage Pharma partner on immuno-oncology programme
CRO secures extended agreement with UK-based biotech firm
Preclinical contract research organisation (CRO), Aquila BioMedical — now part of Concept Life Sciences group, has secured an extended agreement with UK-based biotech firm, Macrophage Pharma, to support its preclinical immune-oncology programmes. Read more
